AHArie Johan Hoogendijk

Arie Johan Hoogendijk

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Arie Johan Hoogendijk has a total of 87 co-authors. Here are the top co-authors by number of shared publications:

  • Tom van der Poll

    Center for Infection and Immunity Amsterdam (CINIMA), Academic Medical Center/University of Amsterdam, Amsterdam, The Netherlands; Center for Experimental and Molecular Medicine (CEMM), Academic Medical Center/University of Amsterdam, Amsterdam, The Netherlands; Division of Infectious Diseases, Academic Medical Center/University of Amsterdam, Amsterdam, The Netherlands

    8 shared publications
  • Tom van der Poll

    Center of Experimental and Molecular Medicine, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, the Netherlands

    7 shared publications
  • Janneke Horn

    Amsterdam UMC Location University of Amsterdam Department of Intensive Care Medicine Amsterdam the Netherlands

    5 shared publications
  • Lonneke A. van Vught

    Center for Experimental and Molecular Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands

    5 shared publications
  • Marc J. M. Bonten

    Department of Medical Microbiology, University Medical Center, Utrecht, The Netherlands

    5 shared publications
  • Marcus Josephus Schultz

    Department of Anaesthesia, General Intensive Care and Pain Management, Division of Cardiothoracic and Vascular Anaesthesia & Critical Care Medicine, Medical University Wien, 1090 Vienna, Austria

    5 shared publications

Latest Publications

  • Molecular Biomarker to Assist in Diagnosing Abdominal Sepsis upon ICU Admission

    by Brendon P. Scicluna, Maryse A. Wiewel, Lonneke A. van Vught, Arie J. Hoogendijk, Augustijn M. Klarenbeek, Marek Franitza, Mohammad R. Toliat, Peter Nürnberg, Janneke Horn, Marc J. Bonten, et al.


  • Open Access

    The host response in critically ill sepsis patients on statin therapy: a prospective observational study

    by Maryse A. Wiewel, Brendon P. Scicluna, Lonneke A. van Vught, Arie J. Hoogendijk, Aeilko H. Zwinderman, René Lutter, Janneke Horn, Olaf L. Cremer, Marc J. Bonten, Marcus J. Schultz, et al.


  • Open Access

    Risk factors, host response and outcome of hypothermic sepsis

    by Maryse A. Wiewel, Matthew B. Harmon, Lonneke A. van Vught, Brendon P. Scicluna, Arie J. Hoogendijk, Janneke Horn, Aeilko H. Zwinderman, Olaf L. Cremer, Marc J. Bonten, Marcus J. Schultz, et al.

    Hypothermia is associated with adverse outcome in patients with sepsis. The objective of this study was to characterize the host immune response in patients with hypothermic sepsis in order to determine if an excessive anti-inflammatory response could explain immunosuppression and adverse outcome. Markers of endothelial activation and integrity were also measured to explore potential alternative mechanisms of hypothermia. Finally we studied risk factors for hypothermia in an attempt to find new clues to the etiology of hypothermia in sepsis. Consecutive patients diagnosed with sepsis within 24 hours after admission to ICUs in two tertiary hospitals in the Netherlands were included in the study (n = 525). Hypothermia was defined as body temperature below 36 °C in the first 24 h of ICU admission. Hypothermia was identified in 186 patients and was independently associated with mortality. Levels of proinflammatory and anti-inflammatory cytokines were not different between groups. Hypothermia was also not associated with an altered response to ex vivo stimulation with lipopolysaccharide in a subset of 15 patients. Risk factors for hypothermia included low body mass index, hypertension and chronic cardiovascular insufficiency. Levels of the endothelial activation marker fractalkine were increased during the first 4 days of ICU stay. Hypothermia during sepsis is independently associated with mortality, which cannot be attributed to alterations in the host immune responses that were measured in this study. Given that risk factors for hypothermic sepsis are mainly cardiovascular and that the endothelial activation marker fractalkine increased in hypothermia, these findings may suggest that vascular dysfunction plays a role in hypothermic sepsis.


  • Open Access

    Impact of HIV infection on the presentation, outcome and host response in patients admitted to the intensive care unit with sepsis; a case control study

    by on behalf of the MARS Consortium, Maryse A. Wiewel, Michaëla A. Huson, Lonneke A. van Vught, Arie J. Hoogendijk, Peter M. C. Klein Klouwenberg, Janneke Horn, René Lutter, Olaf L. Cremer, Marcus J. Schultz, et al.

    Sepsis is a prominent reason for intensive care unit (ICU) admission in patients with HIV. We aimed to investigate the impact of HIV infection on presentation, outcome and host response in sepsis. We performed a prospective observational study in the ICUs of two tertiary hospitals. For the current analyses, we selected all patients diagnosed with sepsis within 24 hours after admission. Host response biomarkers were analyzed in a more homogeneous subgroup of admissions involving HIV-positive patients with pneumosepsis, matched to admissions of HIV-negative patients for age, gender and race. Matching was done by nearest neighbor matching with R package “MatchIt”. We analyzed 2251 sepsis admissions including 41 (1.8 %) with HIV infection (32 unique patients). HIV-positive patients were younger and admission of HIV-positive patients more frequently involved pneumonia (73.2 % versus 48.8 % of admissions of HIV-negative patients, P = 0.004). Disease severity and mortality up to one year after admission did not differ according to HIV status. Furthermore, sequential plasma levels of host response biomarkers, providing insight into activation of the cytokine network, the vascular endothelium and the coagulation system, were largely similar in matched admissions of HIV-positive and HIV-negative patients with pneumosepsis. Sepsis is more often caused by pneumonia in HIV-positive patients. HIV infection has little impact on the disease severity, mortality and host response during sepsis.


  • Open Access

    Plasma fractalkine is a sustained marker of disease severity and outcome in sepsis patients

    by Arie J. Hoogendijk, Maryse A. Wiewel, Lonneke A. van Vught, Brendon P. Scicluna, Hakima Belkasim-Bohoudi, Janneke Horn, Aeilko H. Zwinderman, Peter M. C. Klein Klouwenberg, Olaf L. Cremer, Marc J. Bonten, et al.

    Introduction: Fractalkine is a chemokine implicated as a mediator in a variety of inflammatory conditions. Knowledge of fractalkine release in patients presenting with infection to the Intensive Care Unit (ICU) is highly limited. The primary objective of this study was to establish whether plasma fractalkine levels are elevated in sepsis and associate with outcome. The secondary objective was to determine whether fractalkine can assist in the diagnosis of infection upon ICU admission.Methods: Fractalkine was measured in 1103 consecutive sepsis patients (including 271 patients with community-acquired pneumonia (CAP)) upon ICU admission and at days 2 and 4 thereafter; in 73 ICU patients treated for suspected CAP in whom this diagnosis was refuted in retrospect; and in 5 healthy humans intravenously injected with endotoxin.Results: Compared to healthy volunteers, sepsis patients had strongly elevated fractalkine levels. Fractalkine levels increased with the number of organs failing, were higher in patients presenting with shock, but did not vary by site of infection. Non-survivors had sustained elevated fractalkine levels when compared to survivors. Fractalkine was equally elevated in CAP patients and patients treated for CAP but in whom the diagnosis was retrospectively refuted. Fractalkine release induced by intravenous endotoxin followed highly similar kinetics as the endothelial cell marker E-selectin.Conclusions: Plasma fractalkine is an endothelial cell derived biomarker that, while not specific for infection, correlates with disease severity in sepsis patients admitted to the ICU.


  • Soluble and cell-associated triggering receptor expressed on myeloid cells-1 and -2 in patients with pulmonary tuberculosis

    by Arie J. Hoogendijk, Dana C. Blok, M. Isabel Garcia Laorden, Liesbeth M. Kager, Ivar O. Lede, Wahid Rahman, Rumana Afroz, Paul Bresser, Jaring S. van der Zee, Aniruddha Ghose, et al.


  • Increased intra- and extracellular granzyme expression in patients with tuberculosis

    by M. Isabel Garcia-Laorden, Dana C. Blok, Liesbeth M. Kager, Arie J. Hoogendijk, Gerard J. van Mierlo, Ivar O. Lede, Wahid Rahman, Rumana Afroz, Aniruddha Ghose, Caroline E. Visser, et al.


  • Open Access

    Expression of inhibitory regulators of innate immunity in patients with active tuberculosis

    by Dana C Blok, Liesbeth M Kager, Arie J Hoogendijk, Ivar O Lede, Wahid Rahman, Rumana Afroz, Paul Bresser, Jaring S van der Zee, Aniruddha Ghose, Caroline E Visser, et al.

    Tuberculosis (TB) is an important cause of morbidity and mortality worldwide. Toll-like-receptors (TLRs) are important for the recognition of the causative agent Mycobacterium tuberculosis. Negative regulation of TLRs is necessary to control deleterious inflammatory damage, but could provide a means of immune evasion by M. tuberculosis as well. To obtain insight in the extent of expression of inhibitory regulators of immunity in patients with active TB, peripheral-blood-mononuclear-cells (PBMCs) and plasma were obtained from 54 TB patients and 29 healthy blood donors from Chittagong, Bangladesh. Bilateral alveolar macrophages were obtained from an infected versus a contralateral normal lung segment of 9 patients. Statistical analyses were performed using Mann–Whitney U and Wilcoxon matched pairs testing. Correlations were calculated using the Spearman rho test. PBMCs harvested from TB patients demonstrated increased mRNA expression of IL-1-receptor-associated-kinase-M, suppressor-of-cytokine-signalling-3 and Toll-interacting-protein. Flow cytometry revealed enhanced expression of IL-1-receptor-like-1 (ST2) on lymphocytes. Plasma soluble ST2 was elevated in patients with TB and correlated with established TB biomarkers, most strongly with soluble interleukin-2 receptor subunit α and interleukin-8. Alveolar macrophage mRNA expression of negative TLR regulators did not differ between the infected and contralateral lung side. These results show enhanced expression of distinct negative regulators of innate immunity in PBMCs of patients with TB and identify plasma soluble ST2 as a potential novel biomarker for TB disease activity.


  • Open Access

    Intrapulmonary administration of a p38 mitogen activated protein kinase inhibitor partially prevents pulmonary inflammation

    by Arie Johan Hoogendijk, Sandra Sofia Pinhanços, Tom van der Poll, Catharina Wilhelmina Wieland